comparemela.com

Latest Breaking News On - Guidance from - Page 6 : comparemela.com

Penumbra (NYSE:PEN) - Penumbra: Q1 Earnings Insights

52-week low: $161.11 Company Profile Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are primarily sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for the neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States.   Related Articles (PEN)

La plus grosse pleine lune de 2021 et les autres

La plus grosse pleine lune de 2021 et les autres
lemonde.fr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lemonde.fr Daily Mail and Mail on Sunday newspapers.

Save 95% off this Ultimate All-Access Business Bundle ft Top Business School Professor

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.